Therefore, our analyses indicate that the CD44+ and CCL2+ TAMs, which played distinctive roles in inflammatory responses and regulating tumor growth, were correlated with the different degrees of malignancy across cancer subtypes, suggesting that the characteristics of TAMs could be used as a marker for different subtypes. The gene discussed is CD44; the disease is cancer.